Obesity / weight management clinical trials recruiting in Texas

116 recruiting obesity / weight management trials match in Texas. Showing 20.

• Evaluating the Impact of a School-based Fruit and Vegetable Co-op on Cardiometabolic Child and Parents Health in a Persistent Poverty AreaRecruiting

  N/A · The University of Texas Health Science Center, Houston · Houston, Texas

• A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinRecruiting

  Phase 3 · Eli Lilly and Company · Dallas, Texas

• A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes MellitusRecruiting

  Phase 3 · AstraZeneca · St Leonards

• A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise HealthyRecruiting

  Phase 1 · Eli Lilly and Company · Dallas, Texas

• A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)Recruiting

  Phase 4 · Eli Lilly and Company · Bellaire, Texas

• A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or OverweightRecruiting

  Phase 3 · Eli Lilly and Company · Austin, Texas

• Postextubation Use of Noninvasive Respiratory Support in Severely Obese PatientsRecruiting

  N/A · Rush University Medical Center · Houston, Texas

• A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)Recruiting

  Phase 3 · Pfizer · Bradenton, Florida

• A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body WeightRecruiting

  Phase 3 · Novo Nordisk A/S · Houston, Texas

• A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes MellitusRecruiting

  Phase 3 · AstraZeneca · Houston, Texas

• A Study of Eloralintide (LY3841136) in Female Participants With Obesity or OverweightRecruiting

  Phase 1 · Eli Lilly and Company · Dallas, Texas

• UTSW NORC Pilot Spinal Cord Injury Dietary ProgramRecruiting

  N/A · University of Texas Southwestern Medical Center · Dallas, Texas

• Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric BypassRecruiting

  N/A · Boston Scientific Corporation · Houston, Texas

• Genetic Disorders of Obesity Program DatabaseRecruiting

  N/A · Baylor College of Medicine · Houston, Texas

• A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related ComorbiditiesRecruiting

  Phase 3 · Ascletis Pharma (China) Co., Limited · Austin, Texas

• Reducing Obesity Through Play Among Toddlers: Tiny Steps to Health (TSHS) StudyRecruiting

  N/A · University of Houston · Houston, Texas

• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or OverweightRecruiting

  Phase 3 · Eli Lilly and Company · San Antonio, Texas

• A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMRecruiting

  Phase 3 · AstraZeneca · Dallas, Texas

• Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral AdiposityRecruiting

  N/A · University of Texas Southwestern Medical Center · Dallas, Texas

• A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or TirzepatideRecruiting

  Phase 2 · Eli Lilly and Company · Houston, Texas

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.